Top Gap Ups and Downs on Thursday: NVS, PGR, INFY and More
Gaps can show signals that something important has happened to the fundamental or the psychology of traders that accompanies this market movement.
Press Release: Doximity to Release Fiscal 2025 First Quarter Results on August 8, 2024
Doximity to Release Fiscal 2025 First Quarter Results on August 8, 2024 SAN FRANCISCO--(BUSINESS WIRE)--July 18, 2024-- Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical
Express News | Doximity Shares Are Trading Lower After Wells Fargo Downgraded the Stock From Equal-Weight to Underweight and Lowered Its Price Target From $27 to $19
Cracking The Code: Understanding Analyst Reviews For Doximity
4 analysts have expressed a variety of opinions on Doximity (NYSE:DOCS) over the past quarter, offering a diverse set of opinions from bullish to bearish.In the table below, you'll find a summary of
Doximity Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/18/2024 -31.53% Wells Fargo $27 → $19 Downgrades Equal-Weight → Underweight 05/17/2024 — Needham
S&P 500 Futures Up In Premarket Trading; Domino's Pizza, Doximity Lag
This article was automatically generated by Barrons.com using technology from Automated Insights. With U.S. stock markets set to open in two hours, Warner Bros. Discovery Inc. Series A (WBD) was up 7.
Express News | Doximity Shares Down 3.4% Premarket After Wells Fargo Cuts to Underweight From Equal Weight
Express News | Doximity Inc : Wells Fargo Cuts to Underweight From Equal Weight; Cuts Target Price to $19 From $27
Wells Fargo Downgrades Doximity(DOCS.US) to Sell Rating, Cuts Target Price to $19
Wells Fargo analyst Stan Berenshteyn downgrades $Doximity(DOCS.US)$ to a sell rating, and adjusts the target price from $27 to $19.According to TipRanks data, the analyst has a success rate of 57.1%
Doximity (DOCS) Stock Moves -1.23%: What You Should Know
Evercore Maintains Doximity(DOCS.US) With Hold Rating, Maintains Target Price $29
Evercore analyst Elizabeth Anderson CFA maintains $Doximity(DOCS.US)$ with a hold rating, and maintains the target price at $29.According to TipRanks data, the analyst has a success rate of 37.7%
We Like These Underlying Return On Capital Trends At Doximity (NYSE:DOCS)
There are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and find a company with returns on capital employed (ROCE) that are increasing, in c
Doximity(DOCS.US) Director Sells US$70,000 in Common Stock
$Doximity(DOCS.US)$ Director Wampler Kira Scherer sold 2,500 shares of common stock on Jul 1, 2024 at an average price of $28 for a total value of $70,000.Source: Announcement What is statement of cha
Doximity (DOCS) Ascends While Market Falls: Some Facts to Note
Morgan Stanley Maintains Doximity(DOCS.US) With Sell Rating, Maintains Target Price $25
Morgan Stanley analyst Craig Hettenbach maintains $Doximity(DOCS.US)$ with a sell rating, and maintains the target price at $25.According to TipRanks data, the analyst has a success rate of 0.0% and a
Should You Think About Buying Doximity, Inc. (NYSE:DOCS) Now?
Doximity(DOCS.US) Director Sells US$300K in Common Stock
$Doximity(DOCS.US)$ Director Cabral Timothy S sold 10,000 shares of common stock on Jun 12, 2024 at an average price of $30 for a total value of $300K.Source: Announcement What is statement of changes
Doximity(DOCS.US) Officer Sells US$900.01K in Common Stock
$Doximity(DOCS.US)$ Officer Bryson Anna sold 30,000 shares of common stock on Jun 12, 2024 at an average price of $30.0002 for a total value of $900.01K.Source: Announcement What is statement of chang
Doximity Insider Sold Shares Worth $300,000, According to a Recent SEC Filing
Timothy S Cabral, Director, on June 12, 2024, sold 10,000 shares in Doximity (DOCS) for $300,000. Following the Form 4 filing with the SEC, Cabral has control over a total of 10,258 shares of the comp
Is It Time To Consider Buying Doximity, Inc. (NYSE:DOCS)?
Doximity, Inc. (NYSE:DOCS), might not be a large cap stock, but it led the NYSE gainers with a relatively large price hike in the past couple of weeks. While good news for shareholders, the comp